BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1339@pharmaconomics
DTSTAMP:20260707T023615Z
DTSTART;VALUE=DATE:20260413
DTEND;VALUE=DATE:20260414
SUMMARY:SNY Approval — Dupixent
DESCRIPTION:A final FDA approval decision on Dupixent for allergic fungal rhinosinusitis is expected Apr 13\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1121404/000119312526155930/d133868dex992.htm\n\nTrack it: https://www.pharmaconomics.com/e/1339
URL:https://www.pharmaconomics.com/e/1339
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:SNY catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR